| Stephanie A Ezebuiro, MD | |
|
1000 73rd St Ste 20, West Des Moines, IA 50265-1321 | |
| (515) 223-6794 | |
| Not Available |
| Full Name | Stephanie A Ezebuiro |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 1000 73rd St Ste 20, West Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013437797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-46599 (Iowa) | Primary |
| 207Q00000X | Family Medicine | R-11035 (Iowa) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great River Medical Center | West burlington, IA | Hospital |
| Boone County Hospital | Boone, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Health Care Inc | 8426966755 | 60 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Primary Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588692487 PECOS PAC ID: 8426966755 Enrollment ID: O20031106000487 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Montgomery County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265405310 PECOS PAC ID: 9032015805 Enrollment ID: O20031211000423 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Buena Vista Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780755728 PECOS PAC ID: 3476464421 Enrollment ID: O20040109001054 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Southeast Iowa Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164433884 PECOS PAC ID: 3870496417 Enrollment ID: O20040130000139 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Boone County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467434225 PECOS PAC ID: 7416840335 Enrollment ID: O20040204001048 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Avera Holy Family |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1508810177 PECOS PAC ID: 7113837428 Enrollment ID: O20061104000150 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Montgomery County Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1376539338 PECOS PAC ID: 9032015805 Enrollment ID: O20061104000347 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Curana Health Of Iowa Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730773714 PECOS PAC ID: 9133536113 Enrollment ID: O20210319000455 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Entity Name | Henry County Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871177477 PECOS PAC ID: 9638570740 Enrollment ID: O20210701003616 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie A Ezebuiro, MD 1445 Se Mesa Dr, Waukee, IA 50263-1308 Ph: (202) 558-8470 | Stephanie A Ezebuiro, MD 1000 73rd St Ste 20, West Des Moines, IA 50265-1321 Ph: (515) 223-6794 |
News Archive
In an age of increased integration between physicians and hospitals, regulators should continue to scrutinize proposed hospital mergers and take steps to maintain competition, according to a new paper by experts at Rice University's Baker Institute for Public Policy.
Cornerstone Pharmaceuticals, Inc., a development stage company and leader in the growing field of cancer metabolism-based therapeutics, today announced that its lead compound CPI-613 has been chosen by Informa and Kantar Health as one of the 2014 Top 10 Most Interesting Oncology Projects to Watch.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
A new study suggests that any level of exercise, including low intensity exercise, may extend life expectancy in older males.
› Verified 8 days ago
Jeffrey Charles Schoon, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6010 Mills Civic Pkwy, Suite 200, West Des Moines, IA 50266 Phone: 515-224-9666 Fax: 515-224-5913 | |
Dr. Stephanie M Stitt Cox, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 220, West Des Moines, IA 50266 Phone: 515-875-9410 Fax: 515-875-9412 | |
Robert Kruse, MD, MPH Family Medicine Medicare: Medicare Enrolled Practice Location: 1055 Jordan Creek Pkwy Ste 100, West Des Moines, IA 50266 Phone: 515-358-5950 Fax: 515-358-5951 | |
Dr. Melissa J Thompson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 220, West Des Moines, IA 50266 Phone: 515-875-9410 Fax: 515-875-9412 | |
Meredith Swenson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6010 Mills Civic Pkwy, West Des Moines, IA 50266 Phone: 515-224-9666 | |
Jennifer L Fejfar, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6000 University Ave, Suite 101, West Des Moines, IA 50266 Phone: 515-241-2600 Fax: 515-241-2032 |